Renal Cell Cancer Update

What Clinicians Want to Know About the Management of Relapsed/Refractory Mantle Cell Lymphoma

Informações:

Sinopse

Dr Toby A Eyre from the Oxford University Hospitals NHS Foundation Trust in Oxford, United Kingdom, and Dr Brad S Kahl from Siteman Cancer Center in St Louis, Missouri, discuss the management of relapsed/refractory mantle cell lymphoma. CME information and select publications here (https://www.researchtopractice.com/RRMCL2023)